Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥2.66T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥581.5bn2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥178.4bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥593.5bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥174.7bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥442.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥124.1bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥444.2bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥124.6bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥6.35Tat 2023-03-31Cons.Assets IFRS
Total assets¥6.55Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.75Tat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.76Tat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥2.93Tat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.98Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥2.89Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.54Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥655.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥721.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥483.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.0bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥101.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥22.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥306.2bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥116.8bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥249.452022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥69.942022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥249.362022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥69.912022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.1%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-03-31¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-03-31¥611m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.8bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥0
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥318m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2022-01-01 → 2022-03-31¥524.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2022-01-01 → 2022-03-31¥523.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥59m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥181.3bn
—segment totalrevenue2022-01-01 → 2022-03-31¥581.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥580.9bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥59m
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥186.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 843
ItemContextValueUnit
Equity attributable to owners of parent IFRSPrior1YearInstant3540435000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant3507288000000JPY
Non controlling interests IFRSPrior1YearInstant76326000000JPY
Non controlling interests IFRSCurrentQuarterInstant78962000000JPY
Equity IFRSPrior1YearInstant3616761000000JPY
Equity IFRSCurrentQuarterInstant3586249000000JPY
Liabilities and equity IFRSPrior1YearInstant6548078000000JPY
Liabilities and equity IFRSCurrentQuarterInstant6346628000000JPY
Revenue IFRSPrior1YTDDuration581505000000JPY
Revenue IFRSCurrentYTDDuration665278000000JPY
Cost of sales IFRSPrior1YTDDuration231280000000JPY
Cost of sales IFRSCurrentYTDDuration262332000000JPY
Gross profit IFRSPrior1YTDDuration350224000000JPY
Gross profit IFRSCurrentYTDDuration402946000000JPY
Other operating income IFRSPrior1YTDDuration2616000000JPY
Other operating income IFRSCurrentYTDDuration3439000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration816000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration1299000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration175288000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration201280000000JPY
Operating profit loss IFRSPrior1YTDDuration178368000000JPY
Operating profit loss IFRSCurrentYTDDuration206404000000JPY
Finance income IFRSPrior1YTDDuration5150000000JPY
Finance income IFRSCurrentYTDDuration7483000000JPY
Finance costs IFRSPrior1YTDDuration8819000000JPY
Finance costs IFRSCurrentYTDDuration30741000000JPY
Profit loss before tax IFRSPrior1YTDDuration174699000000JPY
Profit loss before tax IFRSCurrentYTDDuration183146000000JPY
Income tax expense IFRSPrior1YTDDuration50097000000JPY
Income tax expense IFRSCurrentYTDDuration37920000000JPY
Profit loss IFRSPrior1YTDDuration124602000000JPY
Profit loss IFRSCurrentYTDDuration145226000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration124110000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration144684000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration492000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration542000000JPY
Profit loss IFRSPrior1YTDDuration124602000000JPY
Profit loss IFRSCurrentYTDDuration145226000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration69.94
Basic earnings loss per share IFRSCurrentYTDDuration81.52
Diluted earnings loss per share IFRSPrior1YTDDuration69.91
Diluted earnings loss per share IFRSCurrentYTDDuration81.49
Profit loss IFRSPrior1YTDDuration124602000000JPY
Profit loss IFRSCurrentYTDDuration145226000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration420000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration1132000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration20055000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration20474000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration1132000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass